The National Institutes of Health Stroke Scale was originally designed to stratify patients according to stroke severity for clinical trials, and now it is used to predict disposition and prognosticate functional outcome. Many researchers have also adopted it to trend patient progress over time and detect early neurologic deterioration. However, few investigators have reported its utility in monitoring the daily progress of patients hospitalized for stroke. In the present article, the authors discuss the advantages of daily National Institutes of Health Stroke Scale assessments and our clinical experience with this invaluable tool.
BrottTAdamsHPJrOlingerCP. Measurements of acute cerebral infarction: a clinical examination scale. Stroke1989; 20:864–70.
2.
TongDCYenariMAAlbersGWO'BrienMMarksMPMoseleyME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology1998; 50:864–70.
3.
BrottTMarlerJROlingerCP. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke1989; 20:871–5.
4.
SchlegelDJTanneDDemchukAMLevineSRKasnerSE. Multicenter RT PASSG. Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol2004; 61:1061–4.
5.
AdamsHPJrDavisPHLeiraEC. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology1999; 53:126–31.
6.
The Joint Commission. 2015. Disease-specific care certification program: Comprehensive stroke performance measurement implementation guide January 2015. http://www.jointcommission.org/assets/1/6/CSTK_Manual.pdf. (accessed Sept 9 2014).
7.
WitykRJPessinMSKaplanRFCaplanLR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke1994; 25:362–5.
8.
DeGrabaTJHallenbeckJMPettigrewKDDutkaAJKellyBJ. Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke1999; 30:1208–12.
9.
GrottaJCWelchKMFaganSC. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke2001; 32:661–8.
10.
SieglerJEBoehmeAKKumarADGilletteMAAlbrightKCMartin-SchildS. What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?J Stroke Cerebrovasc Dis2013; 22:675–82.
11.
JauchECSaverJLAdamsHPJr. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2013; 44:870–947.
12.
LinzerMYangEHEstesNA3rdWangPVorperianVRKapoorWN. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Clinical efficacy assessment project of the American College of Physicians. Ann Intern Med1997; 126:989–96.
13.
Corey-BloomJThalLJGalaskoD. Diagnosis and evaluation of dementia. Neurology1995; 45:211–8.
14.
HochstenbagMMTwijnstraAWilminkJTWoutersEFTen VeldeGP. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol2000; 48:243–8.
15.
SchererKBedlackRSSimelDL. Does this patient have myasthenia gravis?JAMA2005; 293:1906–14.
16.
AhmedA. When is facial paralysis bell palsy? Current diagnosis and treatment. Cleve Clin J Med2005; 72:398–401, 405.
17.
BhattacharyyaNBaughRFOrvidasL. Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg2008; 139:S47–81.
18.
KasnerSE. Clinical interpretation and use of stroke scales. Lancet Neurol2006; 5:603–12.
19.
Ertl-WagnerBBrandtTSeifartCForstingM. Diagnostic and therapeutic consequences of repeat brain imaging and follow-up vascular imaging in stroke patients. AJNR Am J Neuroradiol1999; 20:37–42.
20.
SchneiderLBLibmanRBKannerR. Utility of repeat brain imaging in stroke. AJNR Am J Neuroradiol1996; 17:1259–63.
21.
GeorgeAJBoehmeAKDunnCR. Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke2014; doi: 10.1111/ijs.12293.
22.
GoldsteinLBBertelsCDavisJN. Interrater reliability of the NIH Stroke Scale. Arch Neurol1989; 46:660–2.
23.
BrunoAJohnsonCS. Pattern of individual National Institutes of Health Stroke Scale item improvements after stroke. Int J Stroke2013; 8:E19.
24.
SaverJLStarkmanSEcksteinM. Methodology of the Field Administration of Stroke Therapy – Magnesium (FAST-MAG) phase 3 trial: part 1 – rationale and general methods. Int J Stroke2014; 9:215–9.
25.
BrunoAKentTACoullBM. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke2008; 39:384–9.
26.
SchwarzSAl-ShajlawiFSickCMeairsSHennericiMG. Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim Infection in Stroke Study (MISS). Stroke2008; 39:1220–7.
27.
SieglerJEBoehmeAKAlbrightKC. A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis2013; 22:e549–56.
28.
SieglerJEMartin-SchildS. Early neurological deterioration (END) after stroke: the end depends on the definition. Int J Stroke2011; 6:211–2.
29.
ThanviBTreadwellSRobinsonT. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J2008; 84:412–7.
30.
JorgensenHSNakayamaHRaaschouHOOlsenTS. Effect of blood pressure and diabetes on stroke in progression. Lancet1994; 344:156–9.
31.
FrankelMRMorgensternLBKwiatkowskiT. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology2000; 55:952–9.
32.
WeimarCKonigIRKraywinkelKZieglerADienerHC, German Stroke Study C. Age and national institutes of health stroke scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke2004; 35:158–62.
33.
BrownDLJohnstonKCWagnerDPHaleyECJr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke2004; 35:147–50.
34.
KwakkelGVeerbeekJMVan WegenEE. Predictive value of the NIHSS for ADL outcome after ischemic hemispheric stroke: does timing of early assessment matter?J Neurol Sci2010; 294:57–61.
35.
QureshiAISuarezJIYahiaAM. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med2003; 31:272–7.
36.
AzarpazhoohMRNicolMBDonnanGA. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke2008; 3:158–64.
37.
ToniDDi AngelantonioEDi MascioMRViniskoRBathPM, proFESS study group. Types of stroke recurrence in patients with ischemic stroke: a substudy from the profess trial. Int J Stroke2014; 9:873–8.
38.
LanghornePStottDJRobertsonL. Medical complications after stroke: a multicenter study. Stroke2000; 31:1223–9.
39.
SaccoRLFoulkesMAMohrJPWolfPAHierDBPriceTR. Determinants of early recurrence of cerebral infarction. The stroke data bank. Stroke1989; 20:983–9.
40.
WooDBroderickJPKothariRU. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke1999; 30:2355–9.
41.
MeyerBCHemmenTMJacksonCMLydenPD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke2002; 33:1261–6.
42.
MeyerBCLydenPD. The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke2009; 4:267–73.
43.
De HaanRHornJLimburgMVan Der MeulenJBossuytP. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke1993; 24:1178–81.
44.
TilleyBCMarlerJGellerNL. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke1996; 27:2136–42.
